BioLife Solutions, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
BioLife Solutions, Inc. (BLFS) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $3.85 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- BioLife Solutions, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $3.85M, a 34.22% decline year-over-year.
- BioLife Solutions, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $4.81M, a 15.72% increase year-over-year.
- BioLife Solutions, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $7.08M, a 33.81% decline year-over-year.
- BioLife Solutions, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $5.90M, a 10.79% increase year-over-year.
- BioLife Solutions, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $22.99M, a 25.64% decline from fiscal 2024.
- BioLife Solutions, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $30.92M, a 6.98% decline from fiscal 2023.
- BioLife Solutions, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $33.24M, a 31.23% increase from fiscal 2022.
- BioLife Solutions, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $25.33M, a 81.53% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.85M 10-Q · filed 2026-08-06 | $8.66M 10-Q · filed 2026-08-06 | $15.74M derived: sum of 3 quarters · filed 2026-08-06 | $21.64M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $4.81M 10-Q · filed 2026-05-07 | $11.88M derived: sum of 2 quarters · filed 2026-05-07 | $17.79M derived: sum of 3 quarters · filed 2026-05-07 | $23.65M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $7.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $12.98M derived: sum of 2 quarters · filed 2026-02-26 | $18.84M derived: sum of 3 quarters · filed 2026-08-06 | $22.99M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $5.90M 10-Q · filed 2025-11-06 | $11.76M derived: sum of 2 quarters · filed 2026-08-06 | $15.92M 10-Q · filed 2025-11-06 | $26.61M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $5.86M 10-Q · filed 2026-08-06 | $10.01M 10-Q · filed 2026-08-06 | $20.70M derived: sum of 3 quarters · filed 2026-08-06 | $26.03M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $4.15M 10-Q · filed 2026-05-07 | $14.85M derived: sum of 2 quarters · filed 2026-05-07 | $20.17M derived: sum of 3 quarters · filed 2026-05-07 | $28.89M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $10.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $16.02M derived: sum of 2 quarters · filed 2026-02-26 | $24.74M derived: sum of 3 quarters · filed 2026-02-26 | $30.92M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $5.33M 10-Q · filed 2025-11-06 | $14.05M derived: sum of 2 quarters · filed 2025-11-06 | $20.23M 10-Q · filed 2025-11-06 | $30.14M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $8.72M 10-Q · filed 2025-08-07 | $14.90M 10-Q · filed 2025-08-07 | $24.81M derived: sum of 3 quarters · filed 2026-02-26 | $33.93M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $6.18M 10-Q · filed 2025-05-08 | $16.09M derived: sum of 2 quarters · filed 2026-02-26 | $25.21M derived: sum of 3 quarters · filed 2026-02-26 | $32.06M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $9.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $19.02M derived: sum of 2 quarters · filed 2026-02-26 | $25.88M derived: sum of 3 quarters · filed 2026-02-26 | $33.24M 10-K · filed 2026-02-26 | $31.67M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | $9.12M 10-Q · filed 2024-11-12 | $15.97M derived: sum of 2 quarters · filed 2024-11-12 | $23.34M 10-Q · filed 2024-11-12 | $31.00M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | $6.86M 10-Q · filed 2024-08-09 | $14.22M 10-Q · filed 2024-08-09 | $21.88M derived: sum of 3 quarters · filed 2025-03-03 | $28.18M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | $7.36M 10-Q · filed 2024-05-10 | $15.03M derived: sum of 2 quarters · filed 2025-03-03 | $21.32M derived: sum of 3 quarters · filed 2025-03-03 | $27.30M derived: sum of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | $7.66M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $13.96M derived: sum of 2 quarters · filed 2025-03-03 | $19.93M derived: sum of 3 quarters · filed 2025-03-03 | $25.33M 10-K · filed 2025-03-03 | ||||
| 2022-09-30 | $6.30M 10-Q · filed 2023-11-09 | $12.27M derived: sum of 2 quarters · filed 2023-11-09 | $17.67M 10-Q · filed 2023-11-09 | $22.74M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-06-30 | $5.97M 10-Q · filed 2023-08-09 | $11.37M 10-Q · filed 2023-08-09 | $16.44M derived: sum of 3 quarters · filed 2024-02-29 | $21.30M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2022-03-31 | $5.40M 10-Q · filed 2023-05-11 | $10.46M derived: sum of 2 quarters · filed 2024-02-29 | $15.33M derived: sum of 3 quarters · filed 2024-02-29 | $17.85M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $9.93M derived: sum of 2 quarters · filed 2024-02-29 | $12.45M derived: sum of 3 quarters · filed 2024-02-29 | $13.96M 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | $4.87M 10-Q · filed 2022-11-09 | $7.39M derived: sum of 2 quarters · filed 2022-11-09 | $8.89M 10-Q · filed 2022-11-09 | $11.06M derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2021-06-30 | $2.52M 10-Q · filed 2022-08-09 | $4.02M 10-Q · filed 2022-08-09 | $6.19M derived: sum of 3 quarters · filed 2023-03-31 | $7.75M derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2021-03-31 | $1.50M 10-Q · filed 2022-05-10 | $3.67M derived: sum of 2 quarters · filed 2023-03-31 | $5.23M derived: sum of 3 quarters · filed 2023-03-31 | $6.37M derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2020-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $3.72M derived: sum of 2 quarters · filed 2023-03-31 | $4.87M derived: sum of 3 quarters · filed 2023-03-31 | $5.98M 10-K · filed 2023-03-31 | ||||
| 2020-09-30 | $1.56M 10-Q · filed 2021-11-15 | $2.71M derived: sum of 2 quarters · filed 2021-11-15 | $3.82M 10-Q · filed 2021-11-15 | $4.68M derived: sum of 4 quarters · filed 2022-03-31 | ||||
| 2020-06-30 | $1.15M 10-Q · filed 2021-08-16 | $2.26M 10-Q · filed 2021-08-16 | $3.12M derived: sum of 3 quarters · filed 2022-03-31 | $3.95M derived: sum of 4 quarters · filed 2022-03-31 | ||||
| 2020-03-31 | $1.11M 10-Q · filed 2021-05-17 | $1.98M derived: sum of 2 quarters · filed 2022-03-31 | $2.81M derived: sum of 3 quarters · filed 2022-03-31 | $3.62M derived: sum of 4 quarters · filed 2022-03-31 | ||||
| 2019-12-31 | $864.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.69M derived: sum of 2 quarters · filed 2022-03-31 | $2.51M derived: sum of 3 quarters · filed 2022-03-31 | $3.04M 10-K · filed 2022-03-31 | ||||
| 2019-09-30 | $829.00K 10-Q · filed 2020-11-09 | $654.00K 10-Q · filed 2019-11-12 | $1.65M derived: sum of 2 quarters · filed 2020-11-09 | $2.18M 10-Q · filed 2020-11-09 | $1.91M 10-Q · filed 2019-11-12 | $2.57M derived: sum of 4 quarters · filed 2020-11-09 | ||
| 2019-06-30 | $818.00K 10-Q · filed 2020-08-10 | $646.00K 10-Q · filed 2019-08-09 | $1.35M 10-Q · filed 2020-08-10 | $1.25M 10-Q · filed 2019-08-09 | $1.74M derived: sum of 3 quarters · filed 2020-08-10 | $2.12M derived: sum of 4 quarters · filed 2020-08-10 | ||
| 2019-03-31 | $531.00K 10-Q · filed 2020-05-29 | $606.00K 10-Q · filed 2019-05-09 | $919.00K derived: sum of 2 quarters · filed 2020-05-29 | $1.30M derived: sum of 3 quarters · filed 2020-05-29 | $1.68M derived: sum of 4 quarters · filed 2020-05-29 | |||
| 2018-12-31 | $388.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-15 | $771.00K derived: sum of 2 quarters · filed 2020-05-15 | $1.15M derived: sum of 3 quarters · filed 2020-05-15 | $1.52M 10-K · filed 2020-05-15 | ||||
| 2018-09-30 | $383.00K 10-Q · filed 2019-11-12 | $757.00K derived: sum of 2 quarters · filed 2019-11-12 | $1.13M 10-Q · filed 2019-11-12 | $1.13M 10-Q · filed 2018-11-08 | ||||
| 2018-06-30 | $374.00K 10-Q · filed 2019-08-09 | $748.00K 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | $373.00K 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | $1.27M 10-K · filed 2019-03-15 | $0.00 10-K · filed 2018-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |